What question did this study set out to answer?

The aim was to evaluate the impact of pharmaceutical care on hypertension therapy outcomes.

January 2, 1997Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy

Pharmacists' Ability to Influence Outcomes of Hypertension Therapy

View Full Paper

Ask AI

Bookmark

Why the study?

Does pharmaceutical care improve blood pressure control in patients with elevated baseline blood pressures?

Population

Patients with elevated baseline blood pressures attending an urban university-affiliated internal medicine…

Comparison

Pharmaceutical care including education about… vs No pharmacist education; interventions relating…

Design

Cohort

Follow-up

average 5 months

Authors

SESteven R. EricksonUniversity of Michigan RSRichard L. SlaughterBuffalo State University HHHenry HalapySt. Michael's Hospital

Discussion

Member takes

Implication

Pharmacist intervention was associated with greater systolic BP reduction; leaves open whether this improves outcomes or warrants practice change.

Key Points

The aim was to evaluate the impact of pharmaceutical care on hypertension therapy outcomes.
Patients with elevated blood pressure were divided into intervention and control groups.
The intervention involved education on hypertension management and pharmacist recommendations to physicians.
Follow-up lasted for an average of 5 months to assess changes in blood pressure.
Intervention group showed a significant decrease in systolic blood pressure (156.5 mm Hg to 144.5 mm Hg, p = 0.001).
Diastolic blood pressure also decreased significantly in the intervention group (91.6 mm Hg to 86.9 mm Hg, p = 0.01).
No significant differences in health-related quality of life scores were found between groups.

Structured PICO

Does pharmaceutical care improve blood pressure control in patients with elevated baseline blood pressures?

Population

Patients with elevated baseline blood pressures attending an urban university-affiliated internal medicine clinic

Intervention

Pharmaceutical care including education about hypertension, drug and nondrug management, assistance to enhance compliance, and pharmacist recommendations to physicians regarding pharmacotherapy

Comparator

No pharmacist education; interventions relating to pharmacotherapy were only physician initiated

Outcome

Change in mean blood pressures (systolic and diastolic) from baseline to final assessmentsurrogate

Pharmacist-led education and pharmacotherapy recommendations significantly improved systolic blood pressure control in patients with hypertension.

Cite This Study

Erickson et al. (1997) studied this question.

synapsesocial.com/papers/6a73dcd78055c84dbef1612f https://doi.org/10.1002/j.1875-9114.1997.tb03687.x

Topics

Hypertension management

View Full Paper

Ask AI

Bookmark

Implication

Pharmacist intervention was associated with greater systolic BP reduction; leaves open whether this improves outcomes or warrants practice change.